Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 4054-4063
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4054
Figure 1
Figure 1 Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer. A: Barcelona Clinic Liver Cancer (BCLC) staging system[2]; B: Hong Kong Liver Cancer (HKLC) staging system[5].
Figure 2
Figure 2 Kaplan-Meier survival curve. A: Kaplan-Meier survival curve according to Barcelona Clinic Liver Cancer (BCLC) staging system; B: Kaplan-Meier survival curve according to Hong Kong Liver Cancer (HKLC) staging system.
Figure 3
Figure 3 Patients receiving curative treatment after assignment to curative treatment groups by Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems.
Figure 4
Figure 4 Comparison of characteristics of patients assigned by Hong Kong Liver Cancer staging system to curative treatment that did and did not receive recommended treatment.
Figure 5
Figure 5 Median survival of patients assigned to curative treatment by Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems.
Figure 6
Figure 6 Median survivals of patients who received the assigned curative treatment according to the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems.